AC
Armistice Capital Portfolio holdings
AUM
$2.64B
1-Year Return
0.99%
This Quarter Return
-19.28%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$913M
AUM Growth
-$312M
(-25%)
Cap. Flow
-$122M
Cap. Flow
% of AUM
-13.36%
Top 10 Holdings %
Top 10 Hldgs %
48.84%
Holding
107
New
32
Increased
23
Reduced
9
Closed
34
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$61.1M |
| 2 |
Energizer
ENR
|
$48.2M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
$31.5M |
| 4 |
SGI
Somnigroup International Inc.
SGI
|
$30M |
| 5 |
WBT
Welbilt, Inc.
WBT
|
$19.5M |
Top Sells
| 1 |
United Therapeutics
UTHR
|
$37.3M |
| 2 |
Harley-Davidson
HOG
|
$37.3M |
| 3 |
Hanesbrands
HBI
|
$36.9M |
| 4 |
Capri Holdings
CPRI
|
$36.7M |
| 5 |
Avis
CAR
|
$32.1M |
Sector Composition
| 1 | Healthcare | 56.06% |
| 2 | Consumer Discretionary | 16.72% |
| 3 | Industrials | 10.87% |
| 4 | Consumer Staples | 8.24% |
| 5 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
CVS Health
CVS
$93.6B
| $10.4M | 0.78% |
158,000
+58,000
| +58% | +$3.8M |
|
27
PTC Therapeutics
PTCT
$4.55B
| $10.3M | 0.78% |
+300,000
| New | +$10.3M |
|
|
PRTK
28
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $10.1M | 0.77% |
1,968,000
+768,000
| +64% | +$3.94M |
|
|
CLLS
29
Cellectis
CLLS
$269M
| $9.81M | 0.74% |
589,000
-11,000
| -2% | -$183K |
|
30
Solid Biosciences
SLDB
$428M
| $8.9M | 0.67% |
22,133
+11,200
| +102% | +$4.5M |
|
31
Marker Therapeutics
MRKR
$11.6M
| $8.26M | 0.63% |
+148,800
| New | +$8.26M |
|
32
Kiora Pharmaceuticals
KPRX
$9.2M
| $8.03M | 0.61% |
3,197
+85
| +3% | +$213K |
|
33
Alphatec Holdings
ATEC
$2.43B
| $7.65M | 0.58% |
3,338,414
+38,000
| +1% | +$87K |
|
34
Ollie's Bargain Outlet
OLLI
$8.18B
| $7.18M | 0.54% |
+108,000
| New | +$7.18M |
|
35
Cedar Fair
FUN
$2.53B
| $7.1M | 0.54% |
+150,000
| New | +$7.1M |
|
|
ACHN
36
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $6.84M | 0.52% |
4,300,000
+2,300,000
| +115% | +$3.66M |
|
37
Advance Auto Parts
AAP
$3.63B
| $6.61M | 0.5% |
+42,000
| New | +$6.61M |
|
38
Target
TGT
$42.3B
| $6.61M | 0.5% |
+100,000
| New | +$6.61M |
|
|
VLRX
39
DELISTED
VALERITAS HOLDINGS INC
VLRX
| $6.46M | 0.49% |
+992,500
| New | +$6.46M |
|
40
Incyte
INCY
$16.9B
| $6.36M | 0.48% |
+100,000
| New | +$6.36M |
|
41
Larimar Therapeutics
LRMR
$337M
| $6.23M | 0.47% |
104,833
+7,833
| +8% | +$465K |
|
42
Five Below
FIVE
$8.46B
| $6.14M | 0.47% |
+60,000
| New | +$6.14M |
|
|
ADMS
43
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $5.62M | 0.43% |
+658,000
| New | +$5.62M |
|
|
FRTX
44
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $5.15M | 0.39% |
13,843
| – | – |
|
|
ALIM
45
DELISTED
Alimera Sciences, Inc.
ALIM
| $4.98M | 0.38% |
462,400
| – | – |
|
46
CRISPR Therapeutics
CRSP
$4.99B
| $4.91M | 0.37% |
+172,000
| New | +$4.91M |
|
|
FLXN
47
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $4.53M | 0.34% |
+400,000
| New | +$4.53M |
|
48
Ovid Therapeutics
OVID
$87.5M
| $3.87M | 0.29% |
+1,600,000
| New | +$3.87M |
|
49
Cenntro
CENN
$26.7M
| $3.26M | 0.25% |
259
+137
| +112% | +$1.72M |
|
50
Catalyst Pharmaceutical
CPRX
$2.48B
| $2.65M | 0.2% |
1,380,000
-292,000
| -17% | -$561K |
|